Wilck M, Barnabas S, Chokephaibulkit K, Violari A, et al. A phase 3 study of safety and immunogenicity of V114, a 15-valent PCV, followed by PPSV23, in children living with HIV. AIDS 2023 Mar 20. doi: 10.1097/QAD.0000000000003551.
PMID: 36939067